June 13, 2015 (LBO) – United States Food and Drug Administration to test Maggi noodles, which was pulled out from Indian shelves, last week foreign media reported.
The Nestle India faced a troublesome period after Indian authorities claimed to have established that Maggi noodles contains excessive levels of lead in MAGGI noodles.
Nestle India exports Maggi noodles to USA, Canada, UK, Australia, Singapore and Africa.
“We have been made aware that the FDA has taken samples of Maggi noodles manufactured in India from third-party importers’ containers for testing, and we have asked the importers to advise us of the outcome of the FDA tests,” the spokeswoman was quoted saying in an in an emailed statement.
However she had said that Nestle does not import, market or distribute Maggi noodles in the United States.
buy clomiphene online buy clomiphene online no prescription
“Any Maggi noodle products found on US store shelves are sourced directly by retailers or imported through third-party trade,”
Nestle India said that it has approached the Bombay High Court against the ban of Maggi noodles by central food safety regulator FSSAI and Maharashtra Food and Drug Administration.
“As part of the efforts to resolve the Maggi noodles issue, Nestle India today approached the Bombay High Court, raising issues of interpretation of the Food Safety and Standards Act, 2011 while seeking a judicial review of the order dated June 6, 2015, passed by the Food and Drug Administration (FDA) in Maharashtra and the order dated June 5 passed by FSSAI,” Nestle India said in a filing to the BSE.
“At the same time, we are continuing withdrawal of Maggi noodle products. This action will not interfere with this process.”